The Alliance for Regenerative Medicine releases a sponsored study of the cost-effectiveness analysis of new cell and gene therapies.
Read More
Hospitals post underwhelming purchasing savings following acquisition activity, according to a new paper at NBER.
Read More
An analysis published in JAMA finds that Medicare is wasting about a billion dollars a year purchasing brand-name drugs.
Read More
An analysis in Health Affairs compares hospital, home health and SNF use and variation in Medicare Advantage versus the fee-for-service version.
Read More
A report from the Minnesota Department of Health reveals the variation in hospital pricing.
Read More
McKinsey gives us its perspective on trends in Medicare Advantage star ratings.
Read More
The last in a long series about specialty drug trends, including a look forward.
Read More
Part 3 of a review of the EMD Serono Specialty Drug Digest, focusing on utilization and network management.
Read More
The latest edition of the EMD Serono is loaded with insights on specialty drug use and management.
Read More
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.